Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
0.7338
-0.0084 (-1.13%)
At close: Jan 9, 2026, 4:00 PM EST
0.7300
-0.0038 (-0.52%)
After-hours: Jan 9, 2026, 7:57 PM EST
Trinity Biotech Employees
Trinity Biotech had 401 employees as of December 31, 2024. The number of employees increased by 21 or 5.53% compared to the previous year.
Employees
401
Change (1Y)
21
Growth (1Y)
5.53%
Revenue / Employee
$123,214
Profits / Employee
-$90,970
Market Cap
13.62M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 401 | 21 | 5.53% |
| Dec 31, 2023 | 380 | -18 | -4.52% |
| Dec 31, 2022 | 398 | -79 | -16.56% |
| Dec 31, 2021 | 477 | -66 | -12.15% |
| Dec 31, 2020 | 543 | -36 | -6.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TRIB News
- 19 days ago - Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives - GlobeNewsWire
- 19 days ago - Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests - GlobeNewsWire
- 27 days ago - Trinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances - GlobeNewsWire
- 7 weeks ago - Trinity Biotech Secures Major Regulatory Approval for Offshored and Outsourced Manufacturing of Its Market Leading Uni-Gold Rapid HIV Test, Further Accelerating Financial Performance Transformation - GlobeNewsWire
- 2 months ago - Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test - GlobeNewsWire
- 2 months ago - Trinity Biotech Welcomes Perceptive Advisor's Indication of Potential Debt-to-Equity Conversion - Strengthening Balance Sheet and Supporting Growth - GlobeNewsWire
- 4 months ago - Trinity Biotech Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 5 months ago - Trinity Biotech Appoints Paul Tivnan as Non-Executive Director - GlobeNewsWire